Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Second Sight Medical Products, Inc. (EYES : NSDQ)
 
 • Company Description   
Second Sight Medical Products, Inc. is a medical device company. It develops, manufactures, and markets implantable prosthetic devices to restore some functional vision to blind patients. The Company provides Argus II system, an implantable neurostimulation device for the treatment of outer retinal degenerations, such as retinitis pigmentosa. Second Sight Medical Products, Inc. is headquartered in Sylmar, California.

Number of Employees: 12

 
 • Price / Volume Information   
Yesterday's Closing Price: $5.15 Daily Weekly Monthly
20 Day Moving Average: 5,106,209 shares
Shares Outstanding: 27.91 (millions)
Market Capitalization: $143.73 (millions)
Beta: 3.41
52 Week High: $20.00
52 Week Low: $0.69
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 0.98% -0.11%
12 Week -37.58% -41.53%
Year To Date 175.40% 143.86%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
13170 Telfair Avenue
-
Sylmar,CA 91342
USA
ph: 818-833-5000
fax: 818-833-5067
lwilson@insitecony.com http://www.secondsight.com
 
 • General Corporate Information   
Officers
Matthew Pfeffer - Chief Executive Officer and Director
Gregg Williams - Chairman of the Board
Edward Sedo - Chief Accounting Officer
Jonathan Will McGuire - Director
Aaron Mendelsohn - Director

Peer Information
Second Sight Medical Products, Inc. (ABMD)
Second Sight Medical Products, Inc. (DMDS)
Second Sight Medical Products, Inc. (CPWY.)
Second Sight Medical Products, Inc. (EQUR)
Second Sight Medical Products, Inc. (ECIA)
Second Sight Medical Products, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 81362J209
SIC: 3845
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/20
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 27.91
Most Recent Split Date: 1.00 (0.13:1)
Beta: 3.41
Market Capitalization: $143.73 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 6.84
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: 73.21%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/21 - -153.96
12/31/20 - -9,373.23
09/30/20 - -977.63
ROA
03/31/21 - -86.36
12/31/20 - -356.60
09/30/20 - -291.02
Current Ratio
03/31/21 - 3.98
12/31/20 - 0.83
09/30/20 - 1.11
Quick Ratio
03/31/21 - 3.98
12/31/20 - 0.83
09/30/20 - 1.11
Operating Margin
03/31/21 - -
12/31/20 - -
09/30/20 - -
Net Margin
03/31/21 - -
12/31/20 - -
09/30/20 - -
Pre-Tax Margin
03/31/21 - -
12/31/20 - -
09/30/20 - -4,317.30
Book Value
03/31/21 - 0.75
12/31/20 - -0.03
09/30/20 - 0.02
Inventory Turnover
03/31/21 - -
12/31/20 - -
09/30/20 - 0.48
Debt-to-Equity
03/31/21 - 0.00
12/31/20 - -
09/30/20 - 0.00
Debt-to-Capital
03/31/21 - 0.00
12/31/20 - -
09/30/20 - 0.00
 

Powered by Zacks Investment Research ©